Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NTRS✓SelectedUSD · NTRSGSK vs NTRS performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs NTRS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,644.3%
NTRS return
+6,673.3%
Excess return
-5,028.9%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioNTRSExcessAlpha
1D-0.1%-2.7%+2.6%+0.5%
7D-5.3%-9.0%+3.7%-3.1%
30D-3.7%-2.8%-0.8%-3.0%
3M-7.3%-10.7%+3.5%-4.8%
6M-4.2%-1.3%-2.9%-4.2%
YTD+0.9%+20.5%-19.7%-4.3%
1Y+7.3%+31.7%-24.5%-0.4%
3Y+52.7%+132.8%-80.1%+20.7%
5Y+40.1%+56.0%-15.8%+19.4%
10Y+98.7%+160.7%-62.0%+41.0%
All+1,644.3%+6,673.3%-5,028.9%+324.4%

Cumulative growth

Daily Returns

Daily percentage return beside NTRS.

Daily Out/Under-Performance

Portfolio return minus NTRS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NTRS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded NTRS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling